Abstract

Cardiovascular (CV) calcification is known as sub-clinical atherosclerosis and is recognised as a predictor of CV events and mortality. As yet there is no treatment for CV calcification and conventional CV risk factors are not consistently correlated, leaving clinicians uncertain as to optimum management for these patients. For this reason, a review of studies investigating diet and serum levels of macro- and micronutrients was carried out. Although there were few human studies of macronutrients, nevertheless transfats and simple sugars should be avoided, while long chain ω-3 fats from oily fish may be protective. Among the micronutrients, an intake of 800 μg/day calcium was beneficial in those without renal disease or hyperparathyroidism, while inorganic phosphorus from food preservatives and colas may induce calcification. A high intake of magnesium (≥380 mg/day) and phylloquinone (500 μg/day) proved protective, as did a serum 25(OH)D concentration of ≥75 nmol/L. Although oxidative damage appears to be a cause of CV calcification, the antioxidant vitamins proved to be largely ineffective, while supplementation of α-tocopherol may induce calcification. Nevertheless other antioxidant compounds (epigallocatechin gallate from green tea and resveratrol from red wine) were protective. Finally, a homocysteine concentration >12 µmol/L was predictive of CV calcification, although a plasma folate concentration of >39.4 nmol/L could both lower homocysteine and protect against calcification. In terms of a dietary programme, these recommendations indicate avoiding sugar and the transfats and preservatives found in processed foods and drinks and adopting a diet high in oily fish and vegetables. The micronutrients magnesium and vitamin K may be worthy of further investigation as a treatment option for CV calcification.

Highlights

  • Cardiovascular (CV) calcification is a systemic disease [1] and is an independent predictor of CV events and all-cause mortality in both CV and renal patients [2,3,4,5], while coronary artery calcification (CAC) scoring provides improved predictive ability over conventional risk factor scoring alone [6,7]. CAC may be present both with and without severe flow-limiting lesions, in view of its common occurrence as calcification of the atheroma cap, it has become known as a form of subclinical atherosclerosis and is widely used as a marker for coronary artery disease (CAD) [5]

  • At present there is no specific treatment for arterial calcification; medications such as statins, vasodilators and other therapy for atherosclerosis and calcific aortic stenosis have negligible effect, they are beneficial in lowering low density lipoprotein (LDL), a key risk factor for CAD, preventing against development of flow-limiting lesions and reducing inflammation, an important cause of atherosclerosis [12,13]

  • Among the relatively few studies to have assessed the impact of oxidative stress on CV calcification, Ahmadi et al showed a positive correlation between CAC progression and serum malondialdehyde [119], while Watanabe et al showed that type 2 diabetics with aortic arch calcification had significantly higher levels of oxygen metabolites, which were more predictive of calcification than markers of inflammation [120]

Read more

Summary

Introduction

Cardiovascular (CV) calcification is a systemic disease [1] and is an independent predictor of CV events and all-cause mortality in both CV and renal patients [2,3,4,5], while coronary artery calcification (CAC) scoring provides improved predictive ability over conventional risk factor scoring alone [6,7]. CAC may be present both with and without severe flow-limiting lesions, in view of its common occurrence as calcification of the atheroma cap, it has become known as a form of subclinical atherosclerosis and is widely used as a marker for coronary artery disease (CAD) [5]. At present there is no specific treatment for arterial calcification; medications such as statins, vasodilators and other therapy for atherosclerosis and calcific aortic stenosis have negligible effect, they are beneficial in lowering low density lipoprotein (LDL), a key risk factor for CAD, preventing against development of flow-limiting lesions and reducing inflammation, an important cause of atherosclerosis [12,13]. Since there were few studies of calcification and nutrition, this review was extended to include serum and plasma concentrations of the dietary macro- and micronutrients

Fatty Acids
Carbohydrates
Protein
Calcium
Phosphorus
Magnesium
Vitamin D
Vitamin K
Antioxidants
Vitamin A and Carotenoids
Vitamin C
Vitamin E
Flavonoids and Polyphenols
B Vitamins and Homocysteine
Findings
10. Discussion
11. Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.